Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results
Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, Aug. 14, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company fo...
What is the expected impact of the earnings release on the company's share buyback program or dividend policy, if any?
Are there any forward‑looking statements or risks highlighted that could affect the stock’s volatility in the next 30‑60 days?
What is the market’s reaction to the earnings release (stock price movement, volume) and what are the short‑term trade opportunities?
15 days ago